Dr Craig Allen Bollig, MD | |
500 University Drive, Mc H091, Hershey, PA 17033-0853 | |
(717) 531-8945 | |
(717) 531-6160 |
Full Name | Dr Craig Allen Bollig |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 10 Years |
Location | 500 University Drive, Mc H091, Hershey, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518372655 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD478740 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rutgers Health-rwj Neurosurgery Faculty | 4587613443 | 95 |
News Archive
Santarus, Inc. and Pharming Group NV today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration to obtain marketing approval for RUCONEST (recombinant human C1 esterase inhibitor) 50 U/kg, an investigational drug for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.
Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.
Quest Diagnostics Incorporated today announced that it had agreed to repurchase at a negotiated price 15.4 million shares of its common stock from its largest shareholder, an affiliate of GlaxoSmithKline plc (GSK). Subsequent to the transaction, GSK will no longer hold any shares of common stock of Quest Diagnostics.
› Verified 3 days ago
Entity Name | Rutgers Health-rwj Neurosurgery Faculty |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083738637 PECOS PAC ID: 4587613443 Enrollment ID: O20050118000611 |
News Archive
Santarus, Inc. and Pharming Group NV today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration to obtain marketing approval for RUCONEST (recombinant human C1 esterase inhibitor) 50 U/kg, an investigational drug for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.
Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.
Quest Diagnostics Incorporated today announced that it had agreed to repurchase at a negotiated price 15.4 million shares of its common stock from its largest shareholder, an affiliate of GlaxoSmithKline plc (GSK). Subsequent to the transaction, GSK will no longer hold any shares of common stock of Quest Diagnostics.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Craig Allen Bollig, MD 10 Plum St Fl 5, New Brunswick, NJ 08901-2066 Ph: (732) 235-5530 | Dr Craig Allen Bollig, MD 500 University Drive, Mc H091, Hershey, PA 17033-0853 Ph: (717) 531-8945 |
News Archive
Santarus, Inc. and Pharming Group NV today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration to obtain marketing approval for RUCONEST (recombinant human C1 esterase inhibitor) 50 U/kg, an investigational drug for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.
Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.
Quest Diagnostics Incorporated today announced that it had agreed to repurchase at a negotiated price 15.4 million shares of its common stock from its largest shareholder, an affiliate of GlaxoSmithKline plc (GSK). Subsequent to the transaction, GSK will no longer hold any shares of common stock of Quest Diagnostics.
› Verified 3 days ago
Neerav Goyal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8521 | |
Dr. Scott Walen, M.D., FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-4907 | |
Dr. Jessyka G Lighthall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Dr. Mark E. Whitaker, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-6822 Fax: 717-531-4907 | |
Sohrab Sohrabi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Irina Chaikov, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8521 | |
Heather Schopper, Otolaryngology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |